SELLAS Life Sciences Group (SLS) Short Interest
Nasdaq • SLS • US81642T2096
As of Nov 3, 2026, ORTEX estimated 28% of free float sold short, 7.8 days to cover, cost to borrow 7.7%. Sign up for live short interest data.
Nasdaq • SLS • US81642T2096
As of Nov 3, 2026, ORTEX estimated 28% of free float sold short, 7.8 days to cover, cost to borrow 7.7%. Sign up for live short interest data.
This page tracks how heavily SELLAS Life Sciences Group (Nasdaq:SLS) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
SELLAS Life Sciences Group (Nasdaq: SLS) has a market capitalization of $1.6B. Last close $19.15 (as of 2026-11-18); 52-week range $1.39 to $24.89. ORTEX data as of 2026-11-03: short interest was 27.95% of free float, 7.8 days to cover and the average cost to borrow was 7.7%. Sign up for live short interest data.